Potential New HIV Vaccine/Therapy Target, University of California, San Francisco (UCSF) Study

5/31/2012 7:18:10 AM

After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after infection were better able to control the virus.

Read at ScienceDaily

Read at MedicalXpress

Read at University of California, San Francisco

Read Article at

Related Companies

News Categories

• ScienceDaily

• MedicalXpress

• University of California, San Francisco

• University of California, San Francisco (UCSF)

• Academic / Research - Research news